Skip to main content
main-content

Zeitschrift

Annals of Hematology

Annals of Hematology 12/2020

Ausgabe 12/2020

Inhaltsverzeichnis ( 33 Artikel )

15.09.2020 | Original Article | Ausgabe 12/2020 Open Access

Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors

Stefani Parmentier, Michael Kramer, Swetlana Weller, Ulrich Schuler, Rainer Ordemann, Gabi Rall, Markus Schaich, Martin Bornhäuser, Gerhard Ehninger, Frank Kroschinsky

02.06.2020 | Original Article | Ausgabe 12/2020

Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel

Idit Pazgal, Vered Yahalom, Bruria Shalev, Pia Raanani, Pinhas Stark

11.09.2020 | Original Article | Ausgabe 12/2020

Influence of rs1042713 and rs1042714 polymorphisms of β2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India

Shalini Sinha, Bimal Prasad Jit, A. Raj Kumar Patro, Aisurya Ray, Snehadhini Dehury, Sarmila Sahoo, Rajendra Kumar Behera, Pradeep Kumar Mohanty, Pinaki Panigrahi, Padmalaya Das

15.09.2020 | Original Article | Ausgabe 12/2020 Open Access

Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China

Yuanjun Wu, Qianyu Yao, Ming Zhong, Jianying Wu, Longxu Xie, Linnan Su, Fubing Yu

17.09.2020 | Original Article | Ausgabe 12/2020 Open Access

Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China

Jing Ruan, Wei Zuo, Miao Chen, Chen Yang, Bing Han

11.09.2020 | Original Article | Ausgabe 12/2020 Open Access

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

Cihan Ay, Leonard Perschy, Judit Rejtö, Alexandra Kaider, Ingrid Pabinger

28.05.2020 | Original Article | Ausgabe 12/2020

Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients

Emilia Scalzulli, Gioia Colafigli, Roberto Latagliata, Sara Pepe, Daniela Diverio, Francesca Stocchi, Alessio Di Prima, Fabio Efficace, Maurizio Martelli, Robin Foà, Massimo Breccia

29.08.2020 | Original Article | Ausgabe 12/2020

Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis

Marko Lucijanic, Davor Galusic, Ivan Krecak, Martina Sedinic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic, Rajko Kusec

02.09.2020 | Original Article | Ausgabe 12/2020

Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia

Hitoshi Minamiguchi, Hiroyuki Fujita, Yoshiko Atsuta, Norio Asou, Toru Sakura, Yasunori Ueda, Masashi Sawa, Nobuaki Dobashi, Yasuhiro Taniguchi, Rikio Suzuki, Yoshihito Uchino, Akihiro Tomita, Shigehisa Tamaki, Maki Hagihara, Katsumichi Fujimaki, Masamitsu Yanada, Yoshinobu Maeda, Masako Iwanaga, Noriko Usui, Yukio Kobayashi, Shigeki Ohtake, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Akihiro Takeshita, on behalf of the Japan Adult Leukemia Study Group

13.05.2020 | Original Article | Ausgabe 12/2020

Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study

Chong Wei, Xinxin Cao, Wei Zhang, Yan Zhang, Wei Wang, Lu Zhang, Chen Yang, Jun Feng, Huacong Cai, Miao Chen, Yueying Mao, Daobin Zhou

25.09.2020 | Original Article | Ausgabe 12/2020

A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment

Zegeng Chen, Xiaojie Fang, He Huang, Zhao Wang, Huangming Hong, Meiting Chen, Quanguang Ren, Yuyi Yao, Limei Zhang, Ying Tian, Suxia Lin, Tongyu Lin

30.07.2020 | Original Article | Ausgabe 12/2020

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis

M. Pouyiourou, A. Meyer, A. Stroux, A. Viardot, P. La Rosée, G. Maschmeyer, D. Kämpfe, C. Kahl, V. Vucinic, A. Monecke, C. Hirt, T. Weber, J. Meissner, M. Witzens-Harig, S. Böttcher, H. Schmalenberg, R. Marks, G. Prange-Krex, F. Kroschinsky, E. Hauf, U. Keller, K. Koch, W. Klapper, M. Herold, Christian W. Scholz, on behalf of the East German Study Group for Hematology and Oncology (OSHO)

28.09.2020 | Original Article | Ausgabe 12/2020

Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)

Sora Kang, Hyungwoo Cho, Byeong Seok Sohn, Sung Yong Oh, Won-Sik Lee, Sang Min Lee, Deok-Hwan Yang, Jooryung Huh, Dok Hyun Yoon, Cheolwon Suh

20.04.2020 | Original Article | Ausgabe 12/2020 Open Access

Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma

Andrew Davies, Peter Trask, Judit Demeter, Axel Florschütz, Mathias Hänel, Tomohiro Kinoshita, Ruth Pettengell, Hang Quach, Stephen Robinson, Shalal Sadullah, Juan-Manuel Sancho, Miklos Udvardy, Mathias Witzens-Harig, Andrea Knapp, Wenxin Liu

25.07.2020 | Original Article | Ausgabe 12/2020

Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma

Haizhu Chen, Yan Qin, Jianliang Yang, Peng Liu, Changgong Zhang, Xiaohui He, Shengyu Zhou, Sheng Yang, Lin Gui, Liqiang Zhou, Yan Sun, Yuankai Shi

24.09.2020 | Original Article | Ausgabe 12/2020

Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma

Toshihiro Matsukawa, Keito Suto, Minoru Kanaya, Koh Izumiyama, Koichiro Minauchi, Shota Yoshida, Hisashi Oda, Takuto Miyagishima, Akio Mori, Shuichi Ota, Daigo Hashimoto, Takanori Teshima, North Japan Hematology Study Group (NJHSG)

19.09.2020 | Original Article | Ausgabe 12/2020

Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma

Charles Mesguich, Cyrille Hulin, Valerie Latrabe, Axelle Lascaux, Laurence Bordenave, Elif Hindié, Gerald Marit

26.05.2020 | Original Article | Ausgabe 12/2020 Open Access

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen

Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, Michał Szczyrek, Aleksandra Nowaczyńska, Iwona Homa-Mlak, Szymon Zmorzyński, Kinga Kuśmierczuk, Jacek Sompor, Agata Filip, Teresa Małecka-Massalska, Marek Hus

22.06.2020 | Original Article | Ausgabe 12/2020

Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma

Takashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-ichi Ochi, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Chihiro Yamamoto, Shin-ichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda

25.06.2020 | Original Article | Ausgabe 12/2020

KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients

Salvatore Palmieri, S. Rocco, O. Vitagliano, L. Catalano, C. Cerchione, I. D. Vincelli, A. Scopelliti, M. Gentile, G. Farina, M. Barone, A. Gagliardi, D. Esposito, M. Arcamone, V. Amico, R. Fontana, A. Sementa, A. Sica, G. Svanera, F. Pane, F. Ferrara

01.10.2020 | Original Article | Ausgabe 12/2020

Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status

Yue Lu, Yan-Li Zhao, Jian-Ping Zhang, Min Xiong, Xing-Yu Cao, De-Yan Liu, Rui-Juan Sun, Zhi-Jie Wei, Jia-Rui Zhou, Dao-Pei Lu

17.09.2020 | Original Article | Ausgabe 12/2020

Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT

Satoshi Yamasaki, Jinichi Mori, Junya Kanda, Nobuhiko Imahashi, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Yuta Katayama, Tetsuya Eto, Yukiyasu Ozawa, Satoru Takada, Makoto Onizuka, Masayuki Hino, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada

06.09.2020 | Original Article | Ausgabe 12/2020

Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia

Liat Shargian-Alon, Ofir Wolach, Uri Rozovski, Dafna Yahav, Michal Sela-Navon, Mazal Rubinstein, Nino Oniashvilli, Oren Pasvolsky, Pia Raanani, Moshe Yeshurun

15.04.2020 | Letter to the Editor | Ausgabe 12/2020

Borrelia burgdorferi mimicking central nervous system relapse in diffuse large B cell lymphoma

Marcel Nijland, Martijn Bakker, Kees Meijer, Wouter Plattel

09.06.2020 | Letter to the Editor | Ausgabe 12/2020

Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus–positive plasma cell myeloma

Thomas S. Y. Chan, Alvin H. W. Ip, Rex Au-Yeung, Annie W. K. Pang, Yok-Lam Kwong

25.06.2020 | Letter to the Editor | Ausgabe 12/2020

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection

Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, Elena Vera, Marta Hidalgo, Nieves Lopez, Clara Cuellar, Irene Zamanillo, Rodrigo Íñiguez, Estela Paz-Artal, José M. Aguado, J. Martinez-Lopez

03.07.2020 | Letter to the Editor | Ausgabe 12/2020

Bone marrow coexistence of chronic lymphocytic leukemia and Langerhans cell sarcoma

Magda Zanelli, Stefano Ricci, Maurizio Zizzo, Francesca Sanguedolce, Giovanni Martino, Giulio Fraternali Orcioni, Stefano Ascani

29.08.2020 | Letter to the Editor | Ausgabe 12/2020

Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)

Elena Guillen, Enrique Montagud-Marrahi, Diana M. Rodriguez, Evelyn Hermida, Raul A. Padilla, Miquel Blasco, M. Teresa Cibeira, Rodrigo Martino, Carlos Fernandez de Larrea, J. M. Campistol, Luis F. Quintana

10.09.2020 | Letter to the Editor | Ausgabe 12/2020

Early-stage mantle cell lymphoma—a rare entity with special characteristics and needs for treatment

Lena Specht, on behalf of the International Lymphoma Radiation Oncology Group (ILROG)

17.09.2020 | Letter to the Editor | Ausgabe 12/2020

Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations

Shruthi Suryaprakash, Amy George, Scott Langenburg, Süreyya Savaşan

14.09.2020 | Letter to the Editor | Ausgabe 12/2020

Rare synchronous co-existence of acute myeloid leukemia and hairy cell leukemia in a same patient

Xiaofeng Shi, Qian Jiang, Haiyan You, Yichen Liu, Min Chen, Tiantian Li, Jie Peng, Rong Huang, Jingan Liu, Yilin Zhu, Xiaodong Xi

23.09.2020 | Letter to the Editor | Ausgabe 12/2020

Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm

Matthew Schwede, Irena T. Tan, Danielle F. Atibalentja, Meghan M. Dickman, Kerri E. Rieger, Gabriel N. Mannis

20.11.2020 | ACKNOWLEDGEMENT TO REFEREES | Ausgabe 12/2020

Acknowledgement to referees

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise